在聚光灯下
Clinical Innovation: How digital health solutions are transforming our trials
澳门在线赌城娱乐AstraZeneca is committed to improving equitable access to healthcare for patients globally, including to our innovative product portfolio. 澳门第一赌城在线娱乐的方法 includes integrating programmes into local systems and delivering affordable medicines to patients. We seek to drive positive global health outcomes by:
We are playing our part to address health inequities and eliminate discrimination from the delivery of healthcare. As a company at the forefront of scientific and medical innovation, we are also harnessing the latest digital technologies to support improved access. This includes using the power of data and analytics for early diagnosis, expanding access to the latest medical research and training for healthcare professionals.
We are committed to designing clinical programmes with equity at the forefront – from idea inception to patient care. 澳门第一赌城在线娱乐的方法 is patient-centric, data-driven and science-led. We are improving the diversity of clinical trial participants with strong data foundations, tools and standards to align and track progress, 以及外部伙伴关系. We work with industry groups, regulatory agencies and local community groups to shape 临床试验多样性 policies of the future while delivering for patients today.
We believe people with rare diseases deserve the same attention and investment to find and access therapies as anyone else. As we expand the geographies where our rare disease medicines are available, we continue to build relationships with patient communities early in our development programmes to better understand their needs.